Pharmafile Logo
Pharmafocus logo
Advanced Search

Risperdal

Showing 10 posts of 10 posts found.

Gavel

J&J and Purdue settle Kentucky lawsuits for $39.5 million

December 24, 2015
Sales and Marketing Johnson and Johnson, Kentucky, OxyContin, Purdue Pharma, Risperdal, lawsuits

Johnson & Johnson and Purdue Pharma have settled separate lawsuits with the US state of Kentucky for a total of …

News
Johnson and Johnson image

J&J ‘to pay out $4 billion’ in fresh legal case

November 14, 2013
Sales and Marketing J&J, JJ, Risperdal, fines, hip replacement

Johnson & Johnson is set to pay up to $4 billion to settle thousands of legal cases related to patients …

News
J&J image

J&J hit with $2.2 billion fine

November 5, 2013
Sales and Marketing J&J, JJ, Janssen, Risperdal, antipsychotic, fine

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …

News
manufacturing_compounding

J&J’s prescription drugs unit hit by recall

September 17, 2013
Manufacturing and Production J&J, JJ, Risperdal, Tylenol, recalls

News
J&J image

J&J profits down in Q3

October 17, 2012
Sales and Marketing J&J, JJ, Johnson & Johnson, Q3, Risperdal

Johnson & Johnson has reported a 6.5% year-on-year sales increase to $17.1 billion in the third quarter of 2012, a …

News

New J&J chief still struggling with scandals

July 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Risperdal, Weldon, Xarelto, Zytiga

Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …

Feature
Risperdal image

J&J fined after ‘lying to patients for profit’

April 16, 2012
Medical Communications, Sales and Marketing J&J, JJ, Janssen, Risperdal, US

A US judge has slapped a $1.19 billion fine on Johnson & Johnson after it was found to be downplaying …

News
Risperdal image

J&J to pay $1 billion for Risperdal charges

January 9, 2012
Sales and Marketing J&J, JJ, Janssen, Risperdal

Johnson & Johnson will pay more than $1 billion in the US to resolve a civil investigation into the marketing …

News

Janssen reaches partial agreement over criminal investigation

August 10, 2011
Sales and Marketing Janssen, Risperdal, US, US Justice Department, illegal

Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …

News

Virgo wins Risperdal UK account

June 11, 2010
Medical Communications Janssen, Open Road, Risperdal, Virgo

Janssen-Cilag has called in Virgo Health and Open Road to help boost the fortunes of its injectable antipsychotic drug Risperdal …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026